Perceptive Life Sciences, a fund that has outperformed the market, sold all of its 1 million shares of Novavax in the first few months of 2021 and bought millions more shares of three biopharma/biotech stocks in the same period, according to a restated form the investment firm behind the fund filed with the Securities and Exchange Commission. For a look at the three stocks it bought, CLICK HERE.
An Outperforming Fund Ditched Novavax And Picked Up These 3 Biotech Stocks
- by Alex Clarke
![](https://stockjackpots.com/wp-content/uploads/2021/06/2021-06-19-21_42_10-A-Syringe-and-Vaccine-Text-on-Pink-Background-·-Free-Stock-Photo.png)
Tags:Biopharma InvestmentsBiotech InvestmentsBiotech StocksInvestInvestment FirmInvestorNovavaxOutperforming FundPerceptive Life Sciences FundSecurities and Exchange CommissionSharesStockStock Market